Background: Despite immense interest, robotic-assisted thyroidectomy (RT) remains
INTRODUCTION
Thyroidectomy is a common surgical procedure and the standard cervical open thyroidectomy (OT) has been proven safe and effective under experienced hands [1] . However, to further improve the cosmetic result and increase patient satisfaction, endoscopic approaches with incisions made outside the neck (also known as the extracervical approaches) were developed [2, 3] . In 2007, a South Korean group pioneered using the da Vinci robot (the so-called "roboticassisted thyroidectomy" or RT) to improve the ergonomics of these extracervical approaches [4] .
Currently, the two most-described approaches are the robotic transaxillary approach (RTAA) and the robotic bilateral axillo-breast approach (RBA) [3] . Despite the higher cost, the proponents view that RT offers improved motion of endoscopic instruments, clearer stereoscopic visual field and dampening of physiologic tremors [4] . Since the first report in 2009, [5] there has been immense interest both in the US and other parts of the world with various groups publishing their initial successful experience [6] [7] [8] [9] . However, RT remains controversial. In October 2011, the Food and Drug Administration in the US revoked the approval on the use of the robot in thyroidectomy and parathyroidectomy [10] .
Although recent meta-analyses have found that both RT and OT may have comparable surgical medium to long term outcomes, [11] [12] [13] it remains unclear whether RT could provide a similar level of surgical completeness and oncological outcome as the gold standard OT in the treatment of differentiated thyroid carcinoma (DTC). This is relevant because in some parts of the world, this procedure is done mostly for low-risk DTC [4, 5] . To our knowledge, there have been a few single-institution studies specifically evaluating these aspects [14, 15] . However, as with any meta-analysis, one major advantage of pooling data from various studies is that at times it could highlight interesting and important findings which may not be apparent with individual study due to the lack of power. Therefore, we conducted a systematic review and meta-analysis to compare surgical completeness and/or oncological outcomes between RT and OT.
METHODS
This systematic review and meta-analysis was conducted in accordance with the PRISMA statement [16] .
Search strategy
Studies comparing surgical completeness +/-oncological outcomes between patients with DTC who underwent RT and OT were retrieved from the Scopus, Medline (PubMed) and Cochrane Library electronic databases on 20 th February 2014. We used the following free text search terms in "All fields"
#1: 'robotic thyroidectomy' #2: 'robotic assisted thyroidectomy' #3: 'robot thyroidectomy'
#4: #1 OR #2 OR #3
There was no language restriction or methodological filters. The bibliographies of two previous meta-analyses on RT were searched for other additional relevant references [11, 12] .
Study selection
All titles identified by the search strategy were screened independently by three authors (BHL, JST, KPW). Search results were compared, and disagreements were resolved by consensus.
Abstracts of potentially relevant titles were then reviewed for eligibility and full-length articles were selected for closer examination. Any prospective or retrospective study that compared at least one variable on surgical completeness and /or oncological outcome for DTC was considered. These variables included number of central lymph nodes (CLNs) retrieved during surgery, postoperative stimulated thyroglobulin (sTg) levels, findings on post-therapy radioiodine scan (RxWBS) and locoregional recurrence (LRR). However, we excluded case reports, editorials, expert opinions, reviews without original data, studies on pediatric population, studies comparing outcomes between RT and endoscopic (i.e. non-robotic) thyroidectomy and studies evaluating patients undergoing robotic-assisted lateral neck dissection. For studies with limited data on sTg, LRR and follow-up duration, the corresponding author of those studies was individually contacted for further information. Multiple reports of the same dataset were assessed and the most representative or updated report of a study was included.
Data extraction
All data were extracted onto a standardized form. The primary data extracted from each article included: type or design of study, first authorship, country of origin, year of publication, patient demographics, patient selection for RT and OT, extent of surgery (total thyroidectomy (TT) or less than total thyroidectomy (LTT)), tumor characteristics such as histological type, presence of extrathyroidal extension, multicentricity and bilaterality, tumor size, CLN metastasis, number of CLNs retrieved, TNM stage, pre-ablative sTg, percentage of radioactive iodine uptake (RAIU)
on RxWBS, locoregional recurrence (LRR) and follow-up duration (months). TT included near-TT, TT and TT with central neck dissection (CND) whereas LTT included hemithyroidectomy and subtotal thyroidectomy.
Study quality
The quality of all non-randomized studies was assessed using the Newcastle-Ottawa Scale (NOS) [17] . The NOS considers methods of patient selection, comparability of the study groups and reporting of important outcomes. A maximum rating of 9 may be given to individual studies.
Studies achieving a rating of 5 or more were considered higher quality. Two reviewers (BHL, JST) independently assessed the quality of the studies and disagreement was resolved by consensus. Figure 1 shows the flowchart of studies retrieved and excluded. Of the 485 titles initially identified from the database search, 20 full-length articles were assessed for inclusion, of which 10 were excluded and 10 studies [14, 15, [20] [21] [22] [23] [24] [25] [26] [27] were determined to be eligible and were included in this systematic review. Table 1 lists these 10 excluded articles [28-37] and the reason for their exclusion. No additional study was found from our search of the two bibliographies in previous meta-analyses. [11, 12] Of these 10 articles excluded, 5 were excluded mainly because their data were superseded by later studies. [19, [22] [23] [24] 
Statistical methods

RESULTS
Patient selection
Ultrasonography was used as routine preoperative imaging modality in all studies. [14, 15, [20] [21] [22] [23] [24] [25] [26] [27] The inclusion and exclusion criteria for RT or OT were similar. Inclusions included patient age between 21 -65 years old, size of DTC ≤ 2 -4 cm, thyroid lobe size ≤ 6cm and body mass index ≤ 36. [14, 15, [20] [21] [22] [23] [24] [25] [26] [27] Exclusions included previous neck irradiation, presence of lateral lymph node and distant metastases, and posteriorly located carcinoma. [20, 23, 24, 26] In terms of selecting for RT or OT, 4 studies were based on patient preference [14, 20, 25, 27] while the other 6 studies did not specify their selection method. [15, [21] [22] [23] [24] 26] In one study, [21] patients in the OT group were selected in reverse, chronological consecutive order from the time when the robot was first implemented (i.e. historical controls) while the others were cohort in design. Table 2a shows a comparison of the baseline characteristics between the 10 eligible studies.
Baseline characteristics
There were no randomized trials. Eight studies were retrospective while two were prospective. Table 3 shows a comparison of RAI ablation, postoperative sTg levels, post-therapy findings and LRR between RT and OT. Percentages of RAI ablation were given in 5 studies [14, 15, 23, 24, 27] . provided and compared the percentage of RAIU at the RxWBS. Two studies [15, 24] found comparable RAIU at RxWBS while one recent study found RAIU at RxWBS was significantly higher in the RT group (0.10 vs. 0.05, p=0.002) [27] .
Tumor characteristics
Oncological outcomes
Six studies [14, 15, 22, 23, 26 ,27] compared pre-ablation sTg levels between the two groups. One study [23] also had post-ablation sTg levels while another study [24] only reported nonstimulated Tg levels. Figure 2b shows the forest plot for pre-ablation sTg. The overall mean preablation sTg was significantly higher in RT than that in OT (3.6 ± 6.7ng/mL vs. 2.0 ± 5.0ng/mL, SMD=0.272, 95%CI=0.022 -0.522, p=0.033). When only RTAA was considered, the difference became more significant between the two groups (6.1 ± 9.0ng/mL vs. RT group and after a mean follow-up of 18.6 ± 8.8 months, 1 recurrence was found in the OT group. There was no significant difference in mean follow-up between the two groups (p=0.860).
Sensitivity analysis
Since there were significant differences in study design and size, sensitivity analyses were performed. Findings on extrathyroidal extension, multicentricity, bilaterality, tumor size, CLN metastases, TNM stages, RAI and RxWBS were similar when the two prospective studies [26, 27] were excluded or when the two small studies [21, 24] were excluded from the pooled data.
DISCUSSION
Although RT may have the benefits of superior cosmesis and improved patient satisfaction, [2] [3] [4] it remains a controversial procedure in the West [10] Apart from the higher procedural cost, surgical completeness and oncological safety with RT have not been fully addressed [10, 32] Although previous studies have demonstrated comparable completeness between RT and OT, they were single-institution studies. [14, 15] Our data showed that RT seemed to be less effective in complete removal of thyroid tissue. This point should be kept in mind when a surgeon has to decide for the type of operation especially in high-risk groups such as older males, or patients with a posteriorly-located carcinoma or history of radiotherapy.
Despite the increasing number of publications comparing outcomes between the two procedures, all eligible studies were non-randomized and were subjected to selection biases. This was evident when patient baseline characteristics were being pooled. Patients in RT were significantly younger (40.8 years old vs. 50.3 years old, p<0.001) and more likely to be female (92.8% vs.
86.5%, p<0.001). Also overall the tumors in RT were significantly smaller (7.7 ± 3.3mm and 8.6 ± 4.6mm, p<0.001) and earlier staged (p<0.001). Therefore, based on these findings, tumors in RT belonged to a better risk group and so to some extent, RT was expected to have a more complete surgical resection and better oncological outcome than OT. However, our data shows that RT may be associated with a less complete resection than OT. Of the 6 studies [14, 15, 22, 23, 26, 27] comparing pre-ablation sTg levels, RT had significantly higher mean level than OT (3.6ng/mL vs. 2.0ng/mL, p<0.001) implying that greater amount of residual thyroid tissue was left after surgery. Interestingly, this difference was only found in the RTAA group (6.1ng/mL vs. 2.5ng/mL, p<0.001) and not in the RBA group (1.2ng/mL vs. 1.1ng/mL, p=0.632).
One study also found that the percentage of RAIU on RxWBS after RTAA was also significantly higher than that of the OT (0.10 vs. 0.05, p=0.002) [27] . These findings are in discordant to previous single-institution studies which found the surgical completeness was comparable between RT and OT [14, 15] However, it is worth noting that this was only for patients who underwent TT because both sTg and RAIU only reflect the amount of residual thyroid remnant after TT and not LTT. We postulate that one reason why TT by RTAA might be associated with a less complete thyroid resection is because during RTAA, the surgeon often has difficulty completely removing the contralateral lobe (or the non-tumorous side) when the incision is placed in the opposite axilla [7] . Therefore, we think the most likely source of pre-ablation sTg after RTAA is from the contralateral thyroid remnant and not from the ipsilateral lobe or residual tumor tissue. However, in terms of oncological clearance, we do not believe RTAA would compromise the oncological outcome. This is especially when most of these procedures were done for papillary microcarcinoma and low-risk DTC and so leaving small amount of nontumorous thyroid tissue is unlikely to compromise prognosis when the oncological outcome is already excellent. This is supported by the fact that in one particular study, despite the higher initial pre-ablation level, the post-ablation sTg levels became comparable after 9-12 months (1.73ng/mL vs. 1.55ng/mL, p=0.661) [23] .
Another measurement of surgical completeness was the number of CLNs retrieved during concomitant CND. RT had significantly fewer CLNs retrieved during CND than OT (4.7 vs. 5.5, p<0.001). Although the absolute difference was small (<1 CLN), it was nevertheless statistically significant. Interestingly, this difference was again more evident in RTAA (4.7 vs. 5.7, p<0.001)
than RBA (4.7 vs. 4.8, p=0.806). We believe this might be attributed to a combination of factors.
One factor is the difference in surgical approach because RTAA is essentially a lateral approach while OT is a medial or midline approach. Nevertheless, since the incidence of CLN metastasis was comparable (37.1% vs. 36.9%, p=0.745), we do not believe that RTAA had significantly under-staged the nodal status of DTCs at the time of operation. However, it was difficult to know if these concomitant CNDs were done prophylactically or therapeutically as none of the studies stated this. Regarding the comparison of actual oncological outcome, given that there was only one LRR detected in both groups in a relatively short follow-up period, it was difficult to exactly know if there is really a difference in outcome between RT and OT.
Despite some interesting findings, there are several shortcomings which need acknowledgement.
Firstly, since all eligible studies were non-randomized or of low quality (≤4 by NOS), selection biases could have accounted for some of the differences in surgical completeness. Furthermore, it is unclear whether some studies were truly measuring the same outcome (e.g. sTg or RxWBS).
Secondly, the number of studies eligible for inclusion was relatively small. Since there was significant overlap in dataset between studies and one-fourth of eligible studies were excluded (see Table 1 ). Nevertheless, excluding the two smallest studies did not affect our results. Thirdly, given the very good prognosis (and low risk for LRR) in DTCs, a much larger cohort with significant longer follow-up is necessary to fully evaluate the oncological outcome of RT.
Nevertheless, if one considers pre-ablation sTg level and the percentage of RAIU on RxWBS as surrogates for surgical completeness, it would appear that TT via the RTAA has less complete thyroid resection than TT via the open approach. Lastly, although assessment of publication bias was performed, non-significant p-values do not necessarily imply no publication bias as the number of included studies was relatively small (i.e. low power to detect a real difference).
Conclusion
Despite the significantly fewer number of CLNs retrieved in CND and less complete TT by RTAA, RTAA is unlikely to compromise the oncological outcome of patients with low-risk DTC.
However, given the excellent prognosis with few recurrences in low-risk DTC, a much larger patient cohort with long prospective follow up is necessary to fully evaluate the oncological outcome of RT in the future. 
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